Jean-Paul Kress - Jun 26, 2025 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
CEO and Chairman, Director
Signature
/s/ Sherell Bacchas, Attorney-in-Fact
Stock symbol
VOR
Transactions as of
Jun 26, 2025
Transactions value $
$0
Form type
4
Date filed
6/27/2025, 04:10 PM
Previous filing
Jun 27, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kress Jean-Paul CEO and Chairman, Director C/O VOR BIOPHARMA INC., 100 CAMBRIDGEPARK DRIVE, SUITE 101, CAMBRIDGE /s/ Sherell Bacchas, Attorney-in-Fact 2025-06-27 0001654979

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VOR Employee Stock Option (right to buy) Award $0 +83.3M $0.00 83.3M Jun 26, 2025 Common Stock 83.3M $0.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares underlying the option vest on June 26, 2026, with the remainder vesting in equal monthly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date.